| Name | Walgreens #2349 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 1225 N Turner St, Hobbs, New Mexico 88240 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (575) 393-2767 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced it has completed its acquisition of Nycomed A/S for 9.6 billion Euro on a cash-free, debt-free basis and made Nycomed a wholly owned subsidiary of Takeda effective the same day. Dr. Frank Morich has been named CEO of Nycomed in addition to his current role as Executive Vice President (EVP), International Operations, Takeda Pharmaceuticals International, Inc., a wholly owned subsidiary of Takeda America Holdings, Inc.
There was no question that Nancy Coronado would tell her two young children everything about her breast cancer diagnosis. She and her husband wanted to keep them informed of all aspects of treatment and care.
In patients with an acute heart attack, remote ischemic conditioning - intermittent inflation of a blood pressure cuff to cut off blood flow to the arm during transportation to hospital for acute balloon dilatation - reduces subsequent cardiac symptoms and mortality after acute heart attack.
In light of conflicting and inconclusive clinical data on the benefit of radiation therapy in cancer patients with the BRCA1 and BRCA2 mutation, a clinical review examined the current status of data regarding BRCA1 and BRCA2 deficiency and radiation therapy sensitivity and a potential strategy to intensify the effects of radiation therapy (RT) by poly(ADP-ribose) polymerase inhibitors (PARPi), the pharmacologic drugs under investigation as monotherapy for the treatment of breast cancer in patients with BRCA1 and BRCA2 mutations.
A minimally invasive implant procedure is highly effective in reducing pain and disability for patients with sacroiliac joint (SIJ) dysfunction, reports a clinical trial in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons, published by Wolters Kluwer.
› Verified 5 days ago
| NPI Number | 1083629984 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #02349 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1225 N Turner St, Hobbs, NM 88240 |
| Phone Number | 575-393-2767 |
News Archive
Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced it has completed its acquisition of Nycomed A/S for 9.6 billion Euro on a cash-free, debt-free basis and made Nycomed a wholly owned subsidiary of Takeda effective the same day. Dr. Frank Morich has been named CEO of Nycomed in addition to his current role as Executive Vice President (EVP), International Operations, Takeda Pharmaceuticals International, Inc., a wholly owned subsidiary of Takeda America Holdings, Inc.
There was no question that Nancy Coronado would tell her two young children everything about her breast cancer diagnosis. She and her husband wanted to keep them informed of all aspects of treatment and care.
In patients with an acute heart attack, remote ischemic conditioning - intermittent inflation of a blood pressure cuff to cut off blood flow to the arm during transportation to hospital for acute balloon dilatation - reduces subsequent cardiac symptoms and mortality after acute heart attack.
In light of conflicting and inconclusive clinical data on the benefit of radiation therapy in cancer patients with the BRCA1 and BRCA2 mutation, a clinical review examined the current status of data regarding BRCA1 and BRCA2 deficiency and radiation therapy sensitivity and a potential strategy to intensify the effects of radiation therapy (RT) by poly(ADP-ribose) polymerase inhibitors (PARPi), the pharmacologic drugs under investigation as monotherapy for the treatment of breast cancer in patients with BRCA1 and BRCA2 mutations.
A minimally invasive implant procedure is highly effective in reducing pain and disability for patients with sacroiliac joint (SIJ) dysfunction, reports a clinical trial in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons, published by Wolters Kluwer.
› Verified 5 days ago
News Archive
Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced it has completed its acquisition of Nycomed A/S for 9.6 billion Euro on a cash-free, debt-free basis and made Nycomed a wholly owned subsidiary of Takeda effective the same day. Dr. Frank Morich has been named CEO of Nycomed in addition to his current role as Executive Vice President (EVP), International Operations, Takeda Pharmaceuticals International, Inc., a wholly owned subsidiary of Takeda America Holdings, Inc.
There was no question that Nancy Coronado would tell her two young children everything about her breast cancer diagnosis. She and her husband wanted to keep them informed of all aspects of treatment and care.
In patients with an acute heart attack, remote ischemic conditioning - intermittent inflation of a blood pressure cuff to cut off blood flow to the arm during transportation to hospital for acute balloon dilatation - reduces subsequent cardiac symptoms and mortality after acute heart attack.
In light of conflicting and inconclusive clinical data on the benefit of radiation therapy in cancer patients with the BRCA1 and BRCA2 mutation, a clinical review examined the current status of data regarding BRCA1 and BRCA2 deficiency and radiation therapy sensitivity and a potential strategy to intensify the effects of radiation therapy (RT) by poly(ADP-ribose) polymerase inhibitors (PARPi), the pharmacologic drugs under investigation as monotherapy for the treatment of breast cancer in patients with BRCA1 and BRCA2 mutations.
A minimally invasive implant procedure is highly effective in reducing pain and disability for patients with sacroiliac joint (SIJ) dysfunction, reports a clinical trial in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons, published by Wolters Kluwer.
› Verified 5 days ago
Cvs Pharmacy #10148 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 715 W. Bender Blvd, Hobbs, New Mexico 88240 Phone: (575) 397-4855 | |
Hme Specialists Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1712 N Grimes St, Hobbs, New Mexico 88240 Phone: (505) 888-6500 | |
Albertsons Market Pharmacy #680 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2402 N Grimes St, Hobbs, New Mexico 88240 Phone: (575) 392-4503 | |
Walmart Pharmacy 10-0549 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3800 N Lovington Hwy, Hobbs, New Mexico 88240 Phone: (575) 492-0310 | |
Walgreens #12793 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 801 W Joe Harvey Blvd, Hobbs, New Mexico 88240 Phone: (575) 392-0053 |